NAME,DISTRIBUTION,MEDIAN (IQR),DESCRIPTION,SOURCE,NOTES,CATEGORY,"WORKING NOTES, QUERIES, ACTIONS",NOTES - TBS STUDY
ontx.u5,"LN( -3.963316,0.6457913)",0.019 (0.012 - 0.029),CFR children <5 on TB treatment (HIV-),Jenkins et al 2017,used in d.cfr.tx,Outcomes,,
hivartOR:mn,"MVN: [2.6375681, -0.5683867]",,"ORs of death on TB treatment, (OR HIV+ vs -) x (ART -/+): mean","Jenkins et al 2017, Dodd et al 2017",used in d.cfr.tx,,,
hivartOR:sg,"MVN: [[0.2325509,-0.2325509],[-0.2325509,0.6367345]]",,"ORs of death on TB treatment, (OR HIV+ vs -) x (ART -/+): variance","Jenkins et al 2017, Dodd et al 2017",used in d.cfr.tx,,,
notx.u5,"LN(-0.830113,0.08035318)",0.436 (0.413 - 0.460),CFR children <5 without TB treatment (HIV-),Jenkins et al 2017,used in d.cfr.notx,,,
notxH.u5,"B(77.13050,11.10817)",0.877 (0.852 - 0.899),CFR children <5 without TB treatment (HIV+/ART-),Dodd et al 2017,used in d.cfr.notx,,,
notxHA.u5,"B(15.18683,12.87500)",0.542 (0.478 - 0.605),CFR children <5 without TB treatment (HIV+/ART+),Dodd et al 2017,used in d.cfr.notx,,,
s.soc.testingcov,"B(30.21696,3.35744)",0.900 (0.800 - 1.000),"SAM, SOC: coverage of any testing among presumptives (rest clinical only)",Expert opinion,90% done UG/ZM,,,
s.soc.CXRonly,"B(47.52,47.52)",0.500 (0.400 - 0.600),"SAM, SOC: fraction of those with tests only having CXR (as opposed Xpert Ultra on GA as well)",Expert opinion,50% done UG/ZM,,,
sens.xga,"B(19.4209751059137,7.1831003816393)",0.736 (0.675 - 0.791),sensitivity of Xpert on GA in bac+ children,Kay 2020,,,,
spec.xga,"B(212.720785244704,4.11997443389335)",0.982 (0.976 - 0.988),specificity of Xpert on GA in bac+ children,Kay 2020,,,,
sens.clin,"B(492.167344045368,292.788547574039)",0.627 (0.615 - 0.639),"SOC, at DH/PHC: sensitivity of clinical diagnosis without CXR",Marais 2006,,,,
spec.clin,"B(694.552101135748,76.3159356408868)",0.901 (0.894 - 0.908),"SOC, at DH/PHC: specificity of clinical diagnosis without CXR",Marais 2006,,,,
sens.clinCXR.soc,"B(26.00785,1.572055)",0.943 (0.814 - 0.984),"SOC, at DH/PHC: sensitivity of clinical diagnosis with CXR","Source: TBS Decentralization nested cohort (SAM pop, n=41)",,,,
spec.clinCXR.soc,"B(4.947862,0.9919484)",0.833 (0.436 - 0.991),"SOC, at DH/PHC: specificity of clinical diagnosis with CXR","Source: TBS Decentralization nested cohort (SAM pop, n=41)",,,,
s.TBprev,"B(104,431)",0.194 (0.117 - 0.272),True TB prevalence (committee definition),TB-Speed SAM cohort data,,,,
s.SAMmort,"B(14,87)",0.139 (0.000 - 0.323),SAM: CFR from SAM applicable to all,TB-Speed SAM cohort data,,,,
s.reassess.choice.sp,"B(356,130)",0.733 (0.686 - 0.780),Specificity of choice to reassess,TB-Speed SAM cohort data,,,,
s.reassess.choice.se,"B(42,5)",0.911 (0.822 - 1.000),Sensitivity of choice to reassess,TB-Speed SAM cohort data,,,,
s.reassess.sp,"B(28,10)",0.750 (0.583 - 0.912),Specificity of  reassessment,TB-Speed SAM cohort data,,,,
s.reassess.se,"B(28,15)",0.658 (0.476 - 0.841),Sensitivity of reassessment,TB-Speed SAM cohort data,https://docs.google.com/document/d/1k4gsRi_eDgB-5MDUvmnWlZe_mc-2nT_BmWnfAd7UkOg/edit?pli=1,,,
s.soc.scrcov,"B(696, 3.35744)",0.900 (0.800 - 1.000),Proportion (%) of children being screened for TB when admitted to hospital with SAM,Expert opinion,,,,
s.soc.screen.se,"B(26.00785,1.572055)",0.370 (0.285 - 0.464),Sensitivity of the SOC screening,TB-Speed SAM cohort data,,,,
s.soc.screen.sp,"B(395.0861,102.5034)",0.794 (0.756 - 0.827),Specificity of the SOC screening,TB-Speed SAM cohort data,,,,
,,,,,,,,
,,,,,,,,
s.soc.sc.reassess.choice.se,"B(61,7) ",0.897 (0.819 - 0.975),Sensitivity of choice to rescreen - SOC,TB-Speed SAM cohort data,,,,
s.soc.sc.reassess.choice.sp,"B(67,333)",0.167 (0.076 - 0.259),Specificity of choice to rescreen - SOC,TB-Speed SAM cohort data,,,,
s.who.sc.reassess.choice.se,"B(18,5) ",0.783 (0.588 - 0.977),Sensitivity of choice to rescreen - WHO,TB-Speed SAM cohort data,,,,
s.who.sc.reassess.choice.sp,"B(34,110)",0.236 (0.090 - 0.382),Specificity of choice to rescreen - WHO,TB-Speed SAM cohort data,,,,
s.tbs2s.sc.reassess.choice.se,"B(12,1) ",0.923 (0.769 - 1.000),Sensitivity of choice to rescreen - TBS2S,TB-Speed SAM cohort data,,,,
s.tbs2s.sc.reassess.choice.sp,"B(29,150)",0.162 (0.025 - 0.299),Specificity of choice to rescreen - TBS2S,TB-Speed SAM cohort data,,,,
,,,,,,,,
,,,,,,,,
s.soc.sc.reassess.se,"B(14,47)",0.229 (0.005 - 0.454),Sensitivity of rescreening - SOC,TB-Speed SAM cohort data,,,,
s.soc.sc.reassess.sp,"B(14,33)",0.298 (0.053 - 0.542),Specificity of rescreening - SOC,TB-Speed SAM cohort data,,,,
s.who.sc.reassess.se,"B(3,15)",0.167 (0.000 - 0.597),Sensitivity of rescreening - WHO,TB-Speed SAM cohort data,,,,
s.who.sc.reassess.sp,"B(3,31)",0.088 (0.000 - 0.416),Specificity of rescreening - WHO,TB-Speed SAM cohort data,,,,
s.tbs2s.sc.reassess.se,"B(2,10)",0.167 (0.000 - 0.694),Sensitivity of rescreening - TBS2S,TB-Speed SAM cohort data,,,,
s.tbs2s.sc.reassess.sp,"B(2,11)",0.154 (0.000 - 0.664),Specificity of rescreening - TBS2S,TB-Speed SAM cohort data,,,,
